Author/s
Wu Y.-C.,
Chen C.-S.,
Chan Y.-J.
Year
Language
English
Document Type
Review
Source Title
Journal of the Chinese Medical Association
Publisher
Wolters Kluwer Health

Description

In late December 2019, a previous unidentified coronavirus, currently named as the 2019 novel coronavirus#, emerged from Wuhan, China, and resulted in a formidable outbreak in many cities in China and expanded globally, including Thailand, Republic of Korea, Japan, United States, Philippines, Viet Nam, and our country (as of 2/6/2020 at least 25 countries). The disease is officially named as Coronavirus Disease-2019 (COVID-19, by WHO on February 11, 2020). It is also named as Severe Pneumonia with Novel Pathogens on January 15, 2019 by the Taiwan CDC, the Ministry of Health and is a notifiable communicable disease of the fifth category. COVID-19 is a potential zoonotic disease with low to moderate (estimated 2%-5%) mortality rate. Person-to-person transmission may occur through droplet or contact transmission and if there is a lack of stringent infection control or if no proper personal protective equipment available, it may jeopardize the first-line healthcare workers. Currently, there is no definite treatment for COVID-19 although some drugs are under investigation. To promptly identify patients and prevent further spreading, physicians should be aware of the travel or contact history of the patient with compatible symptoms. Copyright ᄅ 2020, the Chinese Medical Association. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)

Theme
Disease epidemiology and mathematical modelling
Migration angle
Index Keywords

COVID-19; severe acute respiratory syndrome coronavirus 2; Asia; Betacoronavirus; China; Coronavirus infection; disease transmission; global health; human; infection control; pathogenicity; procedures; United States; virus pneumonia; Asia; Betacoronavirus; China; Coronavirus Infections; Global Health; Humans; Infection Control; Infectious Disease Transmission, Patient-to-Professional; Pneumonia, Viral; United States